LYOPHILIZED PRODUCT MARKET ANALYSIS

Lyophilized Product Market, By Drug Class (Anti-infective, Antineoplastic, Diuretics, Proton pump inhibitor, Anesthetic, Anticoagulant, NSAIDs, and Others), By Indication (Infectious Disease, Autoimmune Diseases, Gastrointestinal Diseases, Cancer, and Others), By Packaging Type (Vial, Syringes, and Cartridge), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Feb 2022
Code : CMI4910
Pages :326
Formats :
Excel and PDF
Industry : Pharmaceutical

Lyophilized Product MarketSize and Trends

The global lyophilized product market is estimated to be valued at US$ 393.8 billion in 2021 and is expected to exhibit a CAGR of 7.3% during the forecast period (2021-2028).

Lyophilized Product Market Report Coverage

Figure 1. Global Lyophilized Product Market Share (%) in Terms of Value, By Drug Class, 2021

The increasing prevalence of infectious and autoimmune diseases is expected to drive the market growth during the forecast period

Increasing prevalence of infectious and autoimmune diseases is expected to drive the global lyophilized product market growth over the forecast period. For instance, according to an article published in Microbial Cell in 2020, annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year.